Showing results (781-790 of 909) with videos related to

Sort By:
Pageof 91
BMJ Open|August 25, 2025
Serial cardiac magnetic resonance imaging to assess myocardial inflammation in PET-positive cardiac sarcoidosis under immunomodulatory therapy: a retrospective observational studyJulia Mareen Treiber, Jan Sebastian Wolter, Sören J Backhaus, et al.
Cancer|April 29, 2009
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinomaChristian Wülfing, Jean-Pascal H Machiels, Dirk J Richel, et al.
European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2020
High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults: A Longitudinal Cohort StudyLi Chen, Haidong Zhu, Shaoyong Su, et al.
The International Journal of Cardiovascular Imaging|January 22, 2025
Evaluating pulmonary stenosis and regurgitation impact on cardiac strain and strain rate in a porcine model via magnetic resonance feature trackingSimon F Rösel, Sören J Backhaus, Torben Lange, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2015
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.
Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.
BMC Anesthesiology|April 11, 2015
Predictors of the accuracy of pulse-contour cardiac index and suggestion of a calibration-index: a prospective evaluation and validation studyWolfgang Huber, Jonas Koenig, Sebastian Mair, et al.
ESC Heart Failure|November 10, 2025
Exercise-induced out-of-proportion increase in afterload and impaired right ventricular contractile reserve in HFpEFJan Sebastian Wolter, Alexander Schulz, Torben Lange, et al.
Pageof 91